Most interestingly, TRMT112 was recently described to form an N6-methyladenosine methyltransferase complex with METTL5, which we also found upregulated in NASH, that remodels fatty acid metabolism and promotes HCC tumorigenesis [84]. This evidence concerns the gene METTL5 and metabolic dysfunction-associated steatohepatitis.